This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

PanOptis asks US appeals court to affirm jury verdict in Apple Frand case over LTE patents

( February 13, 2023, 22:31 GMT | Official Statement) -- MLex Summary: PanOptis Patent Management asked a US appeals court to reinstate a $300 million damages verdict against Apple or affirm a judgment on a second verdict in a Frand case involving LTE standard patents. It said that the district court was too solicitous of Apple’s attacks on the verdict by granting an unnecessary retrial on damages. “Apple had agreed (for its own strategic advantage) that evidence regarding Frand obligations should not be permitted at the first trial. And the district court found that Apple had waived any Frand-based objection to the damages verdict, for multiple reasons. But the district court then granted Apple a new trial purely because the jury did not hear the word ‘Frand,’” it argued.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections